Search results for: 'market analyst 2025'
- Did you mean
- market analyst 2014
- market analysi 2025
- Related search terms
- market analysis of rf energy harvesting technolog
- 2025 china servic operations system industry market research report
- market analysi of rf energy harvesting technolog
- market+size+of+china's+overseas+marketing+industry
- market 08 00 00 00
-
19 Sep 2025  |  Global  |  Technology Research
Recent Advances in Biologics, Regenerative Medicine and Radiotherapies
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across recent developments for intelligent drug discovery solutions, precision oncology and novel biologics. The TOE also comprises innovations across stem cell therapies and radiotherapies.The Life Science, Health & Wellness TOE will feature d...
$950.00 -
20 Mar 2026  |  Global  |  Technology Research
Innovations and Growth Opportunities in Cell-based Liver Therapy, Bacteriophage Therapeutics, Cell & Gene Therapy, and Small Molecule Therapeutics
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations transforming respiratory medicine, liver regeneration, metabolic disease management, infectious disease therapeutics, neurological disorders, cardiovascular risk reduction, oncology workflows, and nex...
$950.00 -
30 Nov 2017  |  Europe  |  Market Research
Growth Opportunities in European Prenatal Genetic Testing Market, Forecast to 2021
Non-invasive Prenatal Testing (NIPT) Driven by the Adoption of Next Generation Sequencing (NGS) Techniques for Screening is Driving Market Growth
Prenatal genetic tests are predominantly used to test disorders such as aneuploidies in chromosomes 21, 18, 13 and carrier screens. They are gaining momentum in EU due to enhanced assay outcomes through non-invasive methodologies using next generation sequencing (NGS) techniques, increasing number of women choosing to undergo pregnancy at an advanc...
$3,000.00
Special Price $2,250.00 save 25 %
-
18 Aug 2025  |  Global  |  Market Research
Cell Biology Research Market, Global, 2024–2030
Cell Biology Research is Experiencing Transformational Growth due to Advances in Single-Cell Technologies and Genomics Tools
In the study, Frost & Sullivan examines the global cell biology research market. The market is projected to register high growth between 2024 and 2030, reaching significant revenue milestones. This growth reflects accelerating innovation across instrumentation, consumables, and software platforms, with a firm push from data-driven research models, ...
$4,950.00 -
08 Jul 2026  |  Global  |  Technology Research
Precision Obesity Management: AI-Guided Metabolic Modulation
Emerging Innovations Driving Personalized and Effective Obesity Solutions
The report explores the transformation of obesity care from generalized BMI-based treatment to AI-enabled precision metabolic management. The study highlights how obesity is increasingly recognized as a heterogeneous, multi-pathway disease influenced by genetic, neurobehavioral, metabolic, and environmental factors, requiring personalized therapeut...
$4,950.00 -
17 Jul 2026  |  Global  |  Technology Research
Innovations and Growth Opportunities in AI-Driven Drug Discovery, Precision Diagnostics, Advanced Biologics, and Next-generation Vaccines
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping drug discovery, diagnostics, and therapeutic delivery across oncology, infectious diseases, rare and autoimmune disorders, metabolic and age-related conditions, neurodegenerative and neuromu...
$950.00 -
18 Sep 2026  |  Global  |  Technology Research
Innovations and Growth Opportunities in AI-Enabled Discovery and Diagnostics, Precision Therapeutics, and Next-Generation Vaccine Platforms
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations transforming AI-enabled discovery, precision diagnostics, cell engineering, targeted therapeutics, vaccines, and skin health across oncology, metabolic disease, rare disorders, neuropsychiatry, and ne...
$950.00 -
25 Mar 2026  |  Global  |  Market Research
Global Clinical Diagnostics Industry Growth Opportunities, 2026–2031
Next-Gen AI-Integrated Biomarkers and Smart Automation are Advancing Precision and Early Detection in Molecular and Point-of-Care Diagnostics
The global clinical diagnostics market is poised for strong growth, driven by increased adoption of advanced diagnostics technologies, greater investment in laboratories, and improved access to molecular and immunodiagnostic testing facilities. In 2025, the industry continued its transformation, establishing testing systems as intelligent systems...
$4,950.00 -
18 Sep 2026  |  Global  |  Frost Radar
Frost Radar™: Life Sciences Laboratory Information Management Systems, 2026
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
Laboratory information management systems (LIMS) have been used in life sciences since laboratories began digitizing sample tracking and data management in the 1970s. Modern LIMS solutions enhance efficiency by automating workflows, improving data accuracy, and enabling seamless integration and offer strong compliance, secure centralized data manag...
$4,950.00 -
21 May 2026  |  Global  |  Market Research
Global Molecular Diagnostic Market—Opportunities and Growth Indicators
Unlocking Growth Through Early Disease Detection, Personalized Therapies, and Global Testing Expansion
The molecular diagnostics industry is undergoing consolidation, requiring capital investment and faster regulatory pathways to accelerate clinical adoption. Major diagnostics and life sciences companies are acquiring proprietary testing platforms to strengthen positions in precision oncology and blood-based diagnostics. AI-enabled genomic workflow ...
$2,450.00